Xtant Medical
XTNT
Xtant Medical (XTNT) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.07
- EPS estimate
- −$0.02
- EPS surprise
- −250.00%
- Revenue surprise
- −7.41%
- Revenue
- $23.0M
- Revenue estimate
- $24.9M
- Reported
- Aug 11, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | −$0.02 | −$0.07 | −250.00% | $23.0M | SEC |
| Q1 2026 | May 13, 2026 | −$0.02 | −$0.02 | −33.33% | $20.9M | SEC |
| Q4 2025 | Mar 31, 2026 | −$0.00 | $0.00 | +100.00% | $32.4M | SEC |
| Q3 2025 | Nov 10, 2025 | −$0.01 | $0.01 | +277.36% | $33.3M | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.01 | −$0.09 | −700.00% | $35.4M | SEC |
| Q1 2025 | May 12, 2025 | −$0.01 | $0.28 | +3588.75% | $32.9M | SEC |
| Q4 2024 | Mar 6, 2025 | −$0.01 | −$0.02 | −41.84% | $31.5M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.03 | −$0.04 | −60.00% | $27.9M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.02 | −$0.03 | −41.51% | $29.9M | SEC |
| Q1 2024 | May 15, 2024 | −$0.02 | −$0.03 | −84.05% | $27.9M | SEC |
| Q4 2023 | Apr 1, 2024 | −$0.03 | −$0.03 | −18.58% | $28.1M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.01 | $0.07 | +800.00% | $25.0M | SEC |
| Q2 2023 | Aug 1, 2023 | −$0.02 | −$0.02 | +0.00% | $20.2M | SEC |
| Q1 2023 | May 4, 2023 | −$0.03 | −$0.02 | +33.33% | $17.9M | SEC |
| Q4 2022 | Mar 7, 2023 | $0.00 | −$0.02 | +0.00% | $15.3M | SEC |
| Q4 2021 | Mar 8, 2022 | $0.00 | −$0.03 | +0.00% | $14.0M | — |
| Q3 2021 | Nov 12, 2021 | $0.00 | −$0.02 | +0.00% | $13.8M | — |
| Q1 2021 | May 11, 2021 | $0.00 | $0.00 | +0.00% | $12.5M | — |
| Q4 2020 | Feb 24, 2021 | −$0.12 | −$0.01 | +91.67% | $14.0M | — |
| Q3 2020 | Oct 29, 2020 | −$0.11 | −$0.10 | +9.09% | $14.0M | — |
Quarterly revenue
Frequently asked questions
When did Xtant Medical (XTNT) last report earnings?
Xtant Medical last reported on Aug 11, 2026, covering fiscal Q2 2026.
Did XTNT beat earnings estimates?
No. Xtant Medical reported EPS of −$0.07 for Q2 2026 against a −$0.02 estimate — a 250.00% miss.
How much revenue did XTNT report last quarter?
Xtant Medical reported $23.0M in revenue for Q2 2026, against a consensus estimate of $24.9M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.